Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Are we underestimating the danger of prions and prion based diseases?

Robert Trent
Conditions
January 27, 2021
Share
Tweet
Share

Assessment without definition: a flat tire on the road of progress

Even though we have known about prions for decades, very little progress has been made in defining what a prion is vs. what a prion is not, how they get into the brain, and how prion diseases are different from other neurodegenerative diseases. Phenomenologically these definitions can vary widely. To some, a prion causes a deadly, untestable (in clinical practice), and incurable neurodegenerative disease. To others, a prion is what forms long-term memories. To others still, a prion is what causes anti-fungal resistance and allows life forms to evolve in new environments.

This wide range of variation in how we define what a prion is vs. what a prion does not leads to unproductive conversations among professionals working in relevant fields of study. Subsequently, unproductive conversations lead to delays in scientific progress. I have personally witnessed very well educated individuals talking past each other solely because of poorly established definitions. I believe that we can, and absolutely should, do better in guiding our discussions and research on prions and prion based diseases by establishing a well understood standardized definition. I also believe that this poor definition is putting health care workers and researchers alike at risk for unnecessary exposure.

Without a working definition of what a prion is and what prion based diseases are, we are left unable to assess the risk associated with them. There is evidence that Alzheimer’s is an infectious prion disease. Descriptively, Alzheimer’s has many similarities with Parkinson’s, schizophrenia, and many other diseases.  Since we are mostly using phenomenological definitions of what constitutes a prion, Alzheimer’s and other prion diseases end up becoming undifferentiable, and therefore we cannot say with certainty that Alzheimer’s is not a prion disease.

When we look at the alarmingly high rates of hepatitis C among the elderly that was caused by improper instrument sterilization and not by the drug friendly promiscuous lifestyle of the 60s. One has to consider if the current Alzheimer epidemic has been caused by prion-based diseases acquired from poor surgical sterilization in the 50s. The impact of the Alzheimer’s epidemic has been incredibly severe and more work needs to be done in order to fully understand cause, effect, and then prevention.

Proactive not reactive

Science does not make outright claims that events will either happen or not, but merely ascribes the probability of an event happening based on the initial conditions. Since everything that makes up Cells, organs, and organisms is exponentially dependent on initial conditions, we can’t make definite predictions on large scale events.

This leads me to my next point: I am advocating that we invoke a proactive, rather than reactive stance that Alzheimer’s and other neurodegenerative diseases are infectious prion-based diseases.

This implies that when handling nervous tissue, we should act under the assumption that the nervous tissue contains hitherto unknown infectious prions, even if there are no indicators that this is the case. Nervous tissue is often handled at biosafety level 2 (BSL2). However, most infectious prions (that are known of) are assigned to a biosafety level of 3 (BSL3). When I worked in diagnostics, no testing was ever done on nervous tissue to see if prions were present or not. Given the exceedingly long time it takes for prion-based diseases to cross a threshold of pathology whereby the infection becomes detectable to a clinician, we cannot rely on epidemiological data to ensure health care workers’ safety, we must be proactive and precautious in our actions and not reactive.

Pascal’s wager and gun safety

If you have ever taken a hunter’s education course on gun safety, you will have witnessed an example of Pascal’s wager being applied. The first rule of gun safety is to assume that any gun is loaded and can go off at any time. When carrying a gun, it should always be pointed at the ground and away from anything that might be damaged or injured should the gun go off and fire. These rules are applied and carried out by any responsible gun owner even when they know that the gun is not loaded and that the safety is on. Despite the fact that there is virtually no possible way that the gun could fire a live round, the responsible course of action is to act as if the gun could go off at any time. This paranoid course of action is utilized because the severity of the outcome whereby the gun fires and kills someone is so large that even if the odds are small, the outcome is significant, should the unlikely event occur. This is exactly the approach we should be taking towards handling nervous tissue, prions, and prion based diseases. Pathologists, cytotechnologists, medical school anatomy labs, and etc., should be operating under BSL3 precautions when handling nervous tissue, not BSL2.

Robert Trent is a graduate student.

Image credit: Shutterstock.com

Prev

A surgeon left his own son's funeral to take care of your child

January 27, 2021 Kevin 7
…
Next

14 tips when negotiating a physician job

January 27, 2021 Kevin 0
…

ADVERTISEMENT

Tagged as: Neurology

Post navigation

< Previous Post
A surgeon left his own son's funeral to take care of your child
Next Post >
14 tips when negotiating a physician job

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

More by Robert Trent

  • Biologics are not small molecules: the case for pre-allergy testing in an era of immune-based therapies

    Robert Trent
  • Does the FDA approval of aducanumab mark the return of science-based medicine?

    Robert Trent
  • Getting a second opinion can save lives. It is time we make Miranda rights for patients.

    Robert Trent

Related Posts

  • The expanding role of specialists in value-based care

    Martin Lustick, MD
  • Lessons from the meeting of different value-based concepts

    Joshua Liao, MD
  • Behavioral health providers face challenges in value-based care

    Martin Lustick, MD
  • In crisis, danger and opportunity are present

    Casey P. Schukow, DO
  • Considering the recent setbacks of evidence-based medicine

    Kenneth Lin, MD
  • Market-based approaches solving the opioid epidemic

    Julie Craig, MD

More in Conditions

  • A speech pathologist’s key to better, safer patient care

    Adena Dacy, CCC-SLP
  • How collaboration saved my life from a rare disease doctors couldn’t diagnose

    Tami Burdick
  • Why your emotions are your greatest compass in therapy and life

    Maire Daugharty, MD
  • Patients are not waiting: What MCDA twin parents teach us about shared decision-making

    Stephanie Ernst
  • Health workers deserve care too: How to protect their mental health

    Corey Feist, JD, MBA & Kim Downey, PT
  • Why the words doctors use matter more than they think

    Erin Paterson
  • Most Popular

  • Past Week

    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • Why no medical malpractice firm responded to my scientific protocol

      Howard Smith, MD | Physician
    • A world without antidepressants: What could possibly go wrong?

      Tomi Mitchell, MD | Meds
    • Why funding cuts to academic medical centers impact all of us [PODCAST]

      The Podcast by KevinMD | Podcast
    • Bridging the digital divide: Addressing health inequities through home-based AI solutions

      Dr. Sreeram Mullankandy | Tech
  • Past 6 Months

    • Internal Medicine 2025: inspiration at the annual meeting

      American College of Physicians | Physician
    • The silent crisis hurting pain patients and their doctors

      Kayvan Haddadan, MD | Physician
    • What happened to real care in health care?

      Christopher H. Foster, PhD, MPA | Policy
    • How the CDC’s opioid rules created a crisis for chronic pain patients

      Charles LeBaron, MD | Conditions
    • Are quotas a solution to physician shortages?

      Jacob Murphy | Education
    • How to build a culture where physicians feel valued [PODCAST]

      The Podcast by KevinMD | Podcast
  • Recent Posts

    • Why funding cuts to academic medical centers impact all of us [PODCAST]

      The Podcast by KevinMD | Podcast
    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • When rock bottom is a turning point: Why the turmoil at HHS may be a blessing in disguise

      Muhamad Aly Rifai, MD | Physician
    • How grief transformed a psychiatrist’s approach to patient care

      Devina Maya Wadhwa, MD | Physician
    • A speech pathologist’s key to better, safer patient care

      Adena Dacy, CCC-SLP | Conditions
    • Navigating physician non-competes: a strategy for staying put [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • Why no medical malpractice firm responded to my scientific protocol

      Howard Smith, MD | Physician
    • A world without antidepressants: What could possibly go wrong?

      Tomi Mitchell, MD | Meds
    • Why funding cuts to academic medical centers impact all of us [PODCAST]

      The Podcast by KevinMD | Podcast
    • Bridging the digital divide: Addressing health inequities through home-based AI solutions

      Dr. Sreeram Mullankandy | Tech
  • Past 6 Months

    • Internal Medicine 2025: inspiration at the annual meeting

      American College of Physicians | Physician
    • The silent crisis hurting pain patients and their doctors

      Kayvan Haddadan, MD | Physician
    • What happened to real care in health care?

      Christopher H. Foster, PhD, MPA | Policy
    • How the CDC’s opioid rules created a crisis for chronic pain patients

      Charles LeBaron, MD | Conditions
    • Are quotas a solution to physician shortages?

      Jacob Murphy | Education
    • How to build a culture where physicians feel valued [PODCAST]

      The Podcast by KevinMD | Podcast
  • Recent Posts

    • Why funding cuts to academic medical centers impact all of us [PODCAST]

      The Podcast by KevinMD | Podcast
    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • When rock bottom is a turning point: Why the turmoil at HHS may be a blessing in disguise

      Muhamad Aly Rifai, MD | Physician
    • How grief transformed a psychiatrist’s approach to patient care

      Devina Maya Wadhwa, MD | Physician
    • A speech pathologist’s key to better, safer patient care

      Adena Dacy, CCC-SLP | Conditions
    • Navigating physician non-competes: a strategy for staying put [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...